Intellus Advisors’s Eastman Chemical EMN Stock Holding History
Bought
Maintained
Sold
Other funds holding EMN
Intellus Advisors's EMN Position: Q2 2026 in Review
Intellus Advisors increased its Eastman Chemical (EMN) stake by 2.2% in Q2 2026, buying an estimated $321K and bringing the position to 206,295 shares worth $13.8M. The position accounts for 1.68% of the portfolio, ranked #22.
Intellus Advisors first reported a position in EMN in Q1 2026 and has held it in 2 quarters since. The position peaked at $15.4M in Q1 2026. 642 funds tracked by Wall St. Rank hold EMN as of Q2 2026.
- Intellus Advisors held 206,295 shares of Eastman Chemical worth $13.8M as of Q2 2026.
- Intellus Advisors bought 4,395 Eastman Chemical shares in Q2 2026, an estimated $321K.
- Eastman Chemical made up 1.68% of Intellus Advisors's portfolio in Q2 2026, its #22 holding.
- Intellus Advisors first reported a position in Eastman Chemical in Q1 2026 and has held it in 2 quarters since.
- Intellus Advisors's Eastman Chemical position peaked at $15.4M in Q1 2026.
- 642 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2026.
Based on Intellus Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.